tiprankstipranks
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market
BNTC
Benitec Biopharma
RESEARCH TOOLSreports
Want to see BNTC full AI Analyst Report?

Benitec Biopharma (BNTC) Ratios

313 Followers

Benitec Biopharma Ratios

BNTC's free cash flow for Q4 2026 was AU$0.50. For the 2026 fiscal year, BNTC's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 34.00 34.00 54.67 10.49 0.94
Quick Ratio
 34.00 34.00 54.67 10.49 0.94
Cash Ratio
 33.68 33.68 54.24 10.33 0.62
Solvency Ratio
 -8.00 -8.12 -16.33 -4.31 -4.50
Operating Cash Flow Ratio
 -3.18 -3.09 -13.09 -3.94 -4.53
Short-Term Operating Cash Flow Coverage
 -34.23 -33.30 0.00 0.00 0.00
Net Current Asset Value
AU$ 176.07M$ 176.07M$ 96.22M$ 46.71M$ -533.00K
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 <0.01 0.13
Debt-to-Equity Ratio
 <0.01 <0.01 <0.01 <0.01 2.77
Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 <0.01 0.73
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.03 1.03 1.02 1.11 22.10
Debt Service Coverage Ratio
 17.56 -103.21 12.59 0.00 -580.24
Interest Coverage Ratio
 15.00 0.00 12.71 0.00 -578.21
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 -0.06 0.02 -0.07 0.03 0.43
Net Debt to EBITDA
 3.50 3.50 2.34 2.36 0.10
Profitability Margins
Gross Profit Margin
92.85%0.00%0.00%0.00%-408.00%
EBIT Margin
4412.97%0.00%0.00%0.00%-26038.67%
EBITDA Margin
6145.17%0.00%0.00%0.00%-25530.67%
Operating Profit Margin
6145.17%0.00%0.00%0.00%-25441.33%
Pretax Profit Margin
5467.42%0.00%0.00%0.00%-26082.67%
Net Profit Margin
5467.42%0.00%0.00%0.00%-26082.67%
Continuous Operations Profit Margin
5467.42%0.00%0.00%0.00%-26082.67%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
88.97%88.97%90.79%96.25%102.52%
Return on Assets (ROA)
-24.94%-24.94%-38.07%-41.66%-438.22%
Return on Equity (ROE)
-28.41%-25.73%-38.97%-46.04%-9684.16%
Return on Capital Employed (ROCE)
-28.88%-28.88%-42.71%-47.79%-3926.13%
Return on Invested Capital (ROIC)
-28.80%-28.80%-42.55%-47.50%-2507.36%
Return on Tangible Assets
-24.94%-24.94%-38.07%-41.66%-438.22%
Earnings Yield
-8.85%-7.31%-8.95%-29.20%-347.68%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 1.36
Payables Turnover
 0.00 0.00 1.97 0.25 0.33
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 -0.96 0.00 0.00 0.00 0.12
Asset Turnover
 >-0.01 0.00 0.00 0.00 0.02
Working Capital Turnover Ratio
 >-0.01 0.00 0.00 0.00 0.07
Cash Conversion Cycle
 0.00 0.00 -185.27 -1.44K -824.46
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 267.67
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 185.27 1.44K 1.09K
Operating Cycle
 0.00 0.00 0.00 0.00 267.67
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.36 -0.35 -0.65 -1.89 -13.00
Free Cash Flow Per Share
 -0.37 -0.36 -0.65 -1.91 -13.00
CapEx Per Share
 <0.01 <0.01 <0.01 0.02 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.01 1.00 1.01 1.00
Dividend Paid and CapEx Coverage Ratio
 -160.10 -157.31 -1.31K -108.40 -18.01K
Capital Expenditure Coverage Ratio
 -160.10 -157.31 -1.31K -108.40 -18.01K
Operating Cash Flow Coverage Ratio
 -22.28 -21.68 -27.78 -68.32 -32.22
Operating Cash Flow to Sales Ratio
 20.38 0.00 0.00 0.00 -240.16
Free Cash Flow Yield
-4.50%-2.67%-5.57%-26.29%-320.15%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -11.39 -13.65 -11.14 -3.43 -0.29
Price-to-Sales (P/S) Ratio
 -455.70 0.00 0.00 0.00 75.02
Price-to-Book (P/B) Ratio
 2.91 3.52 4.35 1.58 27.85
Price-to-Free Cash Flow (P/FCF) Ratio
 -22.22 -37.48 -17.95 -3.80 -0.31
Price-to-Operating Cash Flow Ratio
 -30.30 -37.71 -17.96 -3.84 -0.31
Price-to-Earnings Growth (PEG) Ratio
 -0.21 2.05 0.18 0.04 0.01
Price-to-Fair Value
 2.91 3.52 4.35 1.58 27.85
Enterprise Value Multiple
 -3.91 -8.67 -7.90 -1.12 -0.19
Enterprise Value
 200.41M 443.74M 326.75M 23.92M 3.71M
EV to EBITDA
 -3.91 -8.67 -7.90 -1.12 -0.19
EV to Sales
 -240.57 0.00 0.00 0.00 49.45
EV to Free Cash Flow
 -11.73 -26.69 -13.84 -1.22 -0.21
EV to Operating Cash Flow
 -11.80 -26.86 -13.85 -1.23 -0.21
Tangible Book Value Per Share
 3.80 3.80 2.69 4.60 0.15
Shareholders’ Equity Per Share
 3.80 3.80 2.69 4.60 0.15
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 -0.02 0.00 0.00 0.00 0.05
Net Income Per Share
 -0.98 -0.98 -1.05 -2.12 -14.12
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.24 0.00 0.91 1.00 1.00
Research & Development to Revenue
 -30.15 0.00 0.00 0.00 170.32
SG&A to Revenue
 -33.38 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 -22.59 0.00 0.00 0.00 6.03
Income Quality
 0.37 0.36 0.62 0.89 0.92